Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,761
archived clinical trials in
Osteoporosis

Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
The Arthritis Center
mi
from
Palm Harbor, FL
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
The Arthritis Center
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'The Centre for Arthritis and Rheumatic Diseases
mi
from
South Miami, FL
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'The Centre for Arthritis and Rheumatic Diseases
mi
from
South Miami, FL
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Radiant Research - Stuart & LakeWorth
mi
from
Stuart, FL
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Radiant Research - Stuart & LakeWorth
mi
from
Stuart, FL
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Palm Beach Research Center
mi
from
West Palm Beach, FL
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Palm Beach Research Center
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Radiant Research
mi
from
Honolulu, HI
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Radiant Research
mi
from
Honolulu, HI
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Intermountain Orthopaedics
mi
from
Boise, ID
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Intermountain Orthopaedics
mi
from
Boise, ID
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Rush-Prebyterian-St.Luke's Medical Center
mi
from
Chicago, IL
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Rush-Prebyterian-St.Luke's Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
University of Chicago
mi
from
Chicago, IL
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'University Hospital & Outpatient Center
mi
from
Indianapolis, IN
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'University Hospital & Outpatient Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Mercy Arthritis and Osteoporosis Center
mi
from
Des Moines, IA
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Mercy Arthritis and Osteoporosis Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Wichita Clinic
mi
from
Wichita, KA
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Wichita Clinic
mi
from
Wichita, KA
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Ochsner Clinic
mi
from
New Orleans, LA
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Ochsner Clinic
mi
from
New Orleans, LA
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Maine Center for Osteoporosis Research & Education
mi
from
Bangor, ME
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Maine Center for Osteoporosis Research & Education
mi
from
Bangor, ME
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Bethesda Health Research Center
mi
from
Bethesda, MD
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Bethesda Health Research Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'The Osteoporosis and Clinical Trials Center
mi
from
Cumberland, MD
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'The Osteoporosis and Clinical Trials Center
mi
from
Cumberland, MD
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Arthritis and Osteoporosis Center of Maryland
mi
from
Frederick, MD
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Arthritis and Osteoporosis Center of Maryland
mi
from
Frederick, MD
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
The Center for Rheumatology and Bone Research
mi
from
Wheaton, MD
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
The Center for Rheumatology and Bone Research
mi
from
Wheaton, MD
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Michigan Bone and Mineral Clinic, PC
mi
from
Detroit, MI
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Michigan Bone and Mineral Clinic, PC
mi
from
Detroit, MI
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Desoto Family Medical Center
mi
from
Olive Branch, MS
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Desoto Family Medical Center
mi
from
Olive Branch, MS
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'St. John's Medical Research Group
mi
from
Springfield, MO
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'St. John's Medical Research Group
mi
from
Springfield, MO
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Arthritis, Osteoporosis Muscle Skeletal Disease Center
mi
from
Concord, NH
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Arthritis, Osteoporosis Muscle Skeletal Disease Center
mi
from
Concord, NH
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Anderson and Collins Clinical Research Inc.
mi
from
South Plainfield, NJ
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Anderson and Collins Clinical Research Inc.
mi
from
South Plainfield, NJ
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
New Mexico Clinical Research & Osteoporosis Center
mi
from
Albuquerque, NM
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
New Mexico Clinical Research & Osteoporosis Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Lovelace Scientific Resources, Inc.
mi
from
Albuquerque, NM
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Lovelace Scientific Resources, Inc.
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'College of Physicians and Surgeons, Columbia University
mi
from
New York, NY
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'College of Physicians and Surgeons, Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Stony Brook Clinical Research Trials Center
mi
from
Stony Brook, NY
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Stony Brook Clinical Research Trials Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Physicians Clinical Research Services
mi
from
White Plains, NY
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Physicians Clinical Research Services
mi
from
White Plains, NY
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Odyssey Research Services
mi
from
Bismarck, ND
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Odyssey Research Services
mi
from
Bismarck, ND
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Michael J. Lillestol
mi
from
Fargo, ND
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Michael J. Lillestol
mi
from
Fargo, ND
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Altru Health Systems/Altru Research Center
mi
from
Grand Forks, ND
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Altru Health Systems/Altru Research Center
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Odyssey Research Services
mi
from
Minot, ND
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Odyssey Research Services
mi
from
Minot, ND
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
David R. Mandel, M.D., Inc.
mi
from
Mayfield Village, OH
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
David R. Mandel, M.D., Inc.
mi
from
Mayfield Village, OH
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Oklahoma Center for Arthritis Therapy & Research, Inc.
mi
from
Tulsa, OK
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Oklahoma Center for Arthritis Therapy & Research, Inc.
mi
from
Tulsa, OK
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Osteoporosis Center
mi
from
Medford, OR
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Osteoporosis Center
mi
from
Medford, OR
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Clinical Research Center of Reading, LLP
mi
from
West Reading, PA
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Clinical Research Center of Reading, LLP
mi
from
West Reading, PA
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Radiant Research
mi
from
Wyomissing, PA
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Radiant Research
mi
from
Wyomissing, PA
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Rhode Island Hospital
mi
from
Providence, RI
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Roger Williams Medical Center
mi
from
Providence, RI
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Roger Williams Medical Center
mi
from
Providence, RI
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Radiant Research, Inc.
mi
from
Anderson, SC
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Radiant Research, Inc.
mi
from
Anderson, SC
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Columbia Arthritis Center, P.A.
mi
from
Columbia, SC
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Columbia Arthritis Center, P.A.
mi
from
Columbia, SC
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
Radiant Research
mi
from
Greer, SC
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
Radiant Research
mi
from
Greer, SC
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Rapid City Medical Center
mi
from
Rapid City, SD
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Rapid City Medical Center
mi
from
Rapid City, SD
Click here to add this to my saved trials
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated:  11/11/2015
'Averna Research Institute
mi
from
Sioux Falls, SD
Open Label Extension Study of PREOS
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
Status: Enrolling
Updated: 11/11/2015
'Averna Research Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials